Kind Pharmaceutical

Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and development of anemia drugs.

Kind Pharmaceutical is active in the biopharma, biotechnology, health care, therapeutics space based in Asia-Pacific (APAC), founded in 2014.

Kind Pharmaceutical is positioned in biopharma, biotechnology, health care, therapeutics, a segment that rewards a clear, focused offering.

The business is associated with Asia-Pacific (APAC).

Its current recorded stage is Series_B.

Recorded headcount: c_00051_00100 employees.

Total disclosed funding stands at about $50M.

Website: www.kindpharmaceuticals.com